Target intelligence / Profile preview

Glucose-6-phosphate Isomerase (GPI)

Target
GPI
Molecular classification
Enzyme, Isomerase
01

Overview

Glucose-6-phosphate isomerase (GPI) is an enzyme that catalyzes the reversible interconversion of D-glucose-6-phosphate and D-fructose-6-phosphate, a critical step in glycolysis and gluconeogenesis. Beyond its metabolic function, GPI exhibits moonlighting activities, acting as an angiogenic factor, neuroleukin (a neurotrophic factor), and autocrine motility factor promoting cancer cell metastasis. Mutations in GPI can cause glucose phosphate isomerase deficiency, leading to hemolytic anemia and neurological symptoms. In cancer, its overexpression/secretion promotes tumor metastasis.

Other names
Phosphoglucose isomerasePhosphohexose isomeraseAutocrine motility factorAMFNeuroleukinNLKSperm antigen 36SA-36
02

Mechanism of action

Acid/base catalysis: His388 protonates the C5 oxygen; Lys518 deprotonates C1 hydroxyl to open glucose’s ring structure. Substrate rotates about C3-C4; Glu357 abstracts a proton from C2 forming a cis-enediol intermediate stabilized by Arg272. Proton transfer completes conversion to fructose 6-phosphate; substrate ring closes via further rotation and deprotonation by Lys518.

03

Biological functions

GlycolysisGluconeogenesisAngiogenesisNeurotrophic factorCell motilityCytokine activityImmune modulation
04

Disease associations

Glucose phosphate isomerase deficiencyChronic hemolytic anemiaCancer metastasisNeurological disorders (intellectual disability, ataxia)
05

Safety considerations

Mutations can lead to hemolytic anemia and neurological symptomsOverexpression can promote tumor metastasis

Beyond the preview

Go deeper on Glucose-6-phosphate Isomerase (GPI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucose-6-phosphate Isomerase (GPI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call